Oslo
Oslo
Algeta
is developing novel targeted therapies for patients with cancer based on its alpha-pharmaceutical platform... Read moreAlgeta
is developing novel targeted therapies for patients with cancer based on its alpha-pharmaceutical platform... Read more
CEO
- -01/1997
Annual Revenue
<$1M
Employees
<10
News
Apr 17, 2014
PR NEWSWIRE
Press Release: Algeta : Global Radiopharmaceutical Market Report
Mar 14, 2014
SPI WORLD NEWS
Algeta: Thomas Ramdahl appointed Managing Director of Algeta ASA
Feb 26, 2014
WSJ
Algeta: Bayer Says Bid for Algeta Successful
Feb 26, 2014
INDUSTRY WEEK
Algeta: Bayer Buys Norway's Algeta
Feb 26, 2014
GLOBENEWSWIRE
Press Release: Algeta : Algeta ASA: Bayer's voluntary cash offer to acquire the entire issued share capital of Algeta is successful
Feb 26, 2014
SBS
Algeta: Bayer succeeds in buying Norway's Algeta
Feb 24, 2014
WSJ
Algeta: Bayer Clinches Algeta Deal
Feb 24, 2014
REUTERS
Algeta: UPDATE 1-Bayer clinches $2.9 billion deal for Norway's Algeta
Feb 24, 2014
REUTERS
Algeta: Bayer clinches $2.9 billion deal for Norway's Algeta
Feb 05, 2014
RTT NEWS
Algeta: Algeta Turns To Loss In Q4 - Quick Facts